1. A noninterventional, multinational study to assess PD‐L1 expression in cytological and histological lung cancer specimens. Issue 12 (28th July 2020) Authors: Bubendorf, Lukas; Conde, Esther; Cappuzzo, Federico; Langfort, Renata; Schildhaus, Hans‐Ulrich; Votruba, Jiří; Concha‐López, Ángel; Esteban‐Rodriguez, Isabel; Feng, Janine; Devenport, Jenny; Boyiddle, Christine; Morris, Stefanie; Trunzer, Kerstin; Kerr, Keith M. Journal: Cancer cytopathology Issue: Volume 128:Issue 12(2020) Page Start: 928 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Issue 3 (March 2015) Authors: Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial. Issue 3 (March 2015) Authors: Rizvi, Naiyer A; Mazières, Julien; Planchard, David; Stinchcombe, Thomas E; Dy, Grace K; Antonia, Scott J; Horn, Leora; Lena, Hervé; Minenza, Elisa; Mennecier, Bertrand; Otterson, Gregory A; Campos, Luis T; Gandara, David R; Levy, Benjamin P; Nair, Suresh G; Zalcman, Gérard; Wolf, Jürgen; Souquet... Journal: Lancet oncology Issue: Volume 16:Issue 3(2015:Mar.) Page Start: 257 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adherence to AIOM (Italian Association of Medical Oncology) lung cancer guidelines in Italian clinical practice: Results from the RIGHT-3 (research for the identification of the most effective and highly accepted clinical guidelines for cancer treatment) study. Issue 2 (November 2015) Authors: Barni, Sandro; Maiello, Evaristo; Di Maio, Massimo; Ardizzoni, Andrea; Cappuzzo, Federico; Maranzano, Ernesto; Novello, Silvia; Bennati, Chiara; Ori, Alessandra; Rizzoli, Sara; Crinò, Lucio Journal: Lung cancer Issue: Volume 90:Issue 2(2015:Nov.) Page Start: 234 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anaplastic lymphoma kinase gene rearrangements in cytological samples of non–small cell lung cancer: Comparison with histological assessment. Issue 6 (19th March 2014) Authors: Proietti, Agnese; Alì, Greta; Pelliccioni, Serena; Lupi, Cristiana; Sensi, Elisa; Boldrini, Laura; Servadio, Adele; Chella, Antonio; Ribechini, Alessandro; Cappuzzo, Federico; Miccoli, Mario; Fontanini, Gabriella Journal: Cancer cytopathology Issue: Volume 122:Issue 6(2014:Jun.) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Anaplastic lymphoma kinase gene rearrangements in cytological samples of non–small cell lung cancer: Comparison with histological assessment. Issue 6 (19th March 2014) Authors: Proietti, Agnese; Alì, Greta; Pelliccioni, Serena; Lupi, Cristiana; Sensi, Elisa; Boldrini, Laura; Servadio, Adele; Chella, Antonio; Ribechini, Alessandro; Cappuzzo, Federico; Miccoli, Mario; Fontanini, Gabriella Journal: Cancer cytopathology Issue: Volume 122:Issue 6(2014:Jun.) Page Start: 445 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial. Issue 7 (July 2019) Authors: West, Howard; McCleod, Michael; Hussein, Maen; Morabito, Alessandro; Rittmeyer, Achim; Conter, Henry J; Kopp, Hans-Georg; Daniel, Davey; McCune, Steven; Mekhail, Tarek; Zer, Alona; Reinmuth, Niels; Sadiq, Ahad; Sandler, Alan; Lin, Wei; Ochi Lohmann, Tania; Archer, Venice; Wang, Lijia; Kowanetz, M... Journal: Lancet oncology Issue: Volume 20:Issue 7(2019) Page Start: 924 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial. Issue 5 (May 2019) Authors: Reck, Martin; Mok, Tony S K; Nishio, Makoto; Jotte, Robert M; Cappuzzo, Federico; Orlandi, Francisco; Stroyakovskiy, Daniil; Nogami, Naoyuki; Rodríguez-Abreu, Delvys; Moro-Sibilot, Denis; Thomas, Christian A; Barlesi, Fabrice; Finley, Gene; Lee, Anthony; Coleman, Shelley; Deng, Yu; Kowanetz, Marc... Journal: Lancet Issue: Volume 7:Issue 5(2019) Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer. Issue 1 (21st November 2019) Authors: Landi, Lorenza; D'Incà, Federica; Gelibter, Alain; Chiari, Rita; Grossi, Francesco; Delmonte, Angelo; Passaro, Antonio; Signorelli, Diego; Gelsomino, Francesco; Galetta, Domenico; Giannarelli, Diana; Soto Parra, Hector; Minuti, Gabriele; Tiseo, Marcello; Migliorino, Maria Rita; Cognetti, Francesc... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ceritinib for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer. Issue 2 (1st February 2016) Authors: Landi, Lorenza; Cappuzzo, Federico Journal: Expert review of clinical pharmacology Issue: Volume 9:Issue 2(2016) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗